tiprankstipranks
Trending News
More News >

Cytokinetics price target lowered to $53 from $55 at Barclays

Barclays lowered the firm’s price target on Cytokinetics (CYTK) to $53 from $55 and keeps an Overweight rating on the shares following the Q1 report.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1